tiprankstipranks
Staar Surgical Company (STAA)
NASDAQ:STAA
Want to see STAA full AI Analyst Report?

Staar Surgical (STAA) Stock Statistics & Valuation Metrics

574 Followers

Total Valuation

Staar Surgical has a market cap or net worth of $1.31B. The enterprise value is $1.29K.
Market Cap$1.31B
Enterprise Value$1.29K

Share Statistics

Staar Surgical has 50,143,986 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,143,986
Owned by Insiders
Owned by Institutions

Financial Efficiency

Staar Surgical’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -11.26%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-11.26%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee259.98K
Profits Per Employee-87.35K
Employee Count921
Asset Turnover0.52
Inventory Turnover1.03

Valuation Ratios

The current PE Ratio of Staar Surgical is 327.3. Staar Surgical’s PEG ratio is -0.05.
PE Ratio327.3
PS Ratio4.89
PB Ratio3.40
Price to Fair Value3.40
Price to FCF-29.21
Price to Operating Cash Flow-405.11
PEG Ratio-0.05

Income Statement

In the last 12 months, Staar Surgical had revenue of 239.44M and earned -80.45M in profits. Earnings per share was -1.62.
Revenue239.44M
Gross Profit182.42M
Operating Income-45.95M
Pretax Income-82.26M
Net Income-80.45M
EBITDA-73.53M
Earnings Per Share (EPS)-1.62

Cash Flow

In the last 12 months, operating cash flow was -3.25M and capital expenditures -3.50M, giving a free cash flow of -6.75M billion.
Operating Cash Flow-3.25M
Free Cash Flow-6.75M
Free Cash Flow per Share-0.13

Dividends & Yields

Staar Surgical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.01
52-Week Price Change-6.47%
50-Day Moving Average26.87
200-Day Moving Average24.26
Relative Strength Index (RSI)55.37
Average Volume (3m)784.05K

Important Dates

Staar Surgical upcoming earnings date is Nov 4, 2026, After Close (Confirmed).
Last Earnings DateAug 12, 2026
Next Earnings DateNov 4, 2026
Ex-Dividend Date

Financial Position

Staar Surgical as a current ratio of 4.55, with Debt / Equity ratio of 9.84%
Current Ratio4.55
Quick Ratio3.74
Debt to Market Cap0.00
Net Debt to EBITDA1.56
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Staar Surgical has paid -1.81M in taxes.
Income Tax-1.81M
Effective Tax Rate0.02

Enterprise Valuation

Staar Surgical EV to EBITDA ratio is -14.35, with an EV/FCF ratio of -26.34.
EV to Sales4.41
EV to EBITDA-14.35
EV to Free Cash Flow-26.34
EV to Operating Cash Flow-30.82

Balance Sheet

Staar Surgical has $181.49M in cash and marketable securities with $35.94M in debt, giving a net cash position of $145.55M billion.
Cash & Marketable Securities$181.49M
Total Debt$35.94M
Net Cash$145.55M
Net Cash Per Share$2.90
Tangible Book Value Per Share$6.29

Margins

Gross margin is 76.23%, with operating margin of -19.19%, and net profit margin of -33.60%.
Gross Margin76.23%
Operating Margin-19.19%
Pretax Margin-34.36%
Net Profit Margin-33.60%
EBITDA Margin-30.71%
EBIT Margin-34.36%

Analyst Forecast

The average price target for Staar Surgical is $30.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$30.00
Price Target Upside28.31% Upside
Analyst ConsensusHold
Analyst Count7
Revenue Growth Forecast51.30%
EPS Growth Forecast

Scores

Smart Score5
AI Score